Morosini Deborah 4
4 · Prelude Therapeutics Inc · Filed Apr 15, 2021
Insider Transaction Report
Form 4
Morosini Deborah
EVP, Chief of Clinical Affairs
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2021-04-08−100→ 7,546 totalExercise: $1.89Exp: 2030-03-26→ Common Stock (100 underlying) - Sale
Common Stock
2021-04-08$40.00/sh−100$4,000→ 444 total - Exercise/Conversion
Common Stock
2021-04-08$1.89/sh+100$189→ 544 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The stock option is fully vested.